Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Verve Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2023 |
3
| Nickerson Joan (Chief Administrative Officer) has filed a Form 3 on Verve Therapeutics, Inc. |
| 08/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/30/2021 |
3
| Dorval Allison (CFO) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Beam Therapeutics Inc. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Biomatics Capital Partners, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Joung Jae Keith (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Kathiresan Sekar (CEO) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Yeshwant Krishna (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| MacLean Michael F (Director) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Rozen Israel (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Mikhail Sheila (Director) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Evans John M. (Director) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| ARCH Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Bellinger Andrew (Chief Scientific Officer) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| ADELMAN BURT A (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Ticho Barry (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Beaudoin Margaret (Vice President, Finance) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| GV 2019 GP, L.L.C. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Ashe Andrew D. (See Remarks) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Casdin Private Growth Equity Fund, L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Logos Global Management LP (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Broad Institute, Inc. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Rock Springs Capital Management LP (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| FMR LLC (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Novo Holdings A/S (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
| 06/16/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
|
|